StockNews.com began coverage on shares of Seagen (NASDAQ:SGEN – Free Report) in a research note released on Friday morning. The brokerage issued a hold rating on the biotechnology company’s stock. Other research analysts have also recently issued research reports about the company. Morgan Stanley reissued an equal weight rating and issued a $229.00 price target […]